Literature DB >> 2421523

Binding specificity of two monoclonal antiglioma antibodies: immunocytochemical studies using a new tissue embedding technique.

S Krajewski, G Schwendemann, M Weizsäcker, W Wechsler, N de Tribolet.   

Abstract

The binding specificities of two monoclonal antiglioma antibodies (MAB) derived from hybrids GE2 and BF7 (Schnegg et al. 1981) were tested by indirect immunofluorescence (IF) and two immunoperoxidase (IP) methods. Studies were done on biopsies from 33 human CNS tumors, human derived glioma cells, and N-ethylnitrosourea-induced neurogenic rat cells in culture. The immunohistochemical reactions of MAB were investigated in snap-frozen tumor material, conventionally paraffin-embedded material, and tumors embedded in formol sucrose/gum sucrose/paraffin (FSGSP) by the new tissue processing technique of Bolton and Mesnard (1982), which preserves and enhances the antigenicity of tissues. The FSGSP processing offered a better immunocytochemical staining with MAB as compared to cryostat material, while the conventionally embedded paraffin sections of tumors did not stain at all. The binding of MAB revealed an affinity to both glial tumor cells and normal astrocytes. The techniques described are suitable for the identification of an astrocytic subpopulation within gliomas, and may improve the understaining of antigen expression in various stages of astrocytic dedifferentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421523     DOI: 10.1007/bf00687048

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Tumor-specific membrane antigens in established cell lines from gliomas.

Authors:  T Wahlström; E Linder; E Saksela; B Westermark
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

2.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

3.  Protein A, avidin, and biotin in immunohistochemistry.

Authors:  S M Hsu; L Raine
Journal:  J Histochem Cytochem       Date:  1981-11       Impact factor: 2.479

4.  Stem cell sensitivity.

Authors:  M L Rosenblum; M A Gerosa
Journal:  Prog Exp Tumor Res       Date:  1984

5.  Morphological characterization of nitrosourea-induced glioma cell lines and clones.

Authors:  L Ko; A Koestner; W Wechsler
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

6.  Serological analysis of cell surface antigens of malignant human brain tumors.

Authors:  M Pfreundschuh; H Shiku; T Takahashi; R Ueda; J Ransohoff; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.

Authors:  M H Hitchcock; A C Hollinshead; P Chretien; H V Rizzoli
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

8.  Human brain in tissue culture. Part. 5. Identification of glial cells by immunofluorescence.

Authors:  D H Gilden; Z Wroblewska; L F Eng; L B Rorke
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

9.  Characterization of an established human malignant glioma cell line: LN-18.

Authors:  A C Diserens; N de Tribolet; A Martin-Achard; A C Gaide; J F Schnegg; S Carrel
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

10.  Interrelationship between differentiation and malignancy-associated properties in glioma.

Authors:  M C Frame; R I Freshney; P F Vaughan; D I Graham; R Shaw
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

View more
  2 in total

Review 1.  Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system.

Authors:  G Reifenberger; J Szymas; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors.

Authors:  F E Franke; W Schachenmayr; M Osborn; M Altmannsberger
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.